Actively Recruiting
Investigator-initiated Clinical Trial to Observe Conjunctival Goblet Cell Using an Anterior Segment Imaging Device
Led by Seoul National University Hospital · Updated on 2024-06-20
148
Participants Needed
1
Research Sites
102 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
Conjunctival goblet cells secrete mucin, vital for tear film stability. Dysfunction can cause tear film issues and lead to diseases like dry eye. Imaging these cells is crucial for diagnosis and treatment. 0.5% moxifloxacin eye drops, an FDA-approved antibiotic, are used to treat bacterial eye infections and prevent infections before surgeries. The investigators developed a non-invasive imaging method for goblet cells, validated in animals, and now plan to test it in humans for diagnosing and treating ocular surface diseases.
CONDITIONS
Official Title
Investigator-initiated Clinical Trial to Observe Conjunctival Goblet Cell Using an Anterior Segment Imaging Device
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Adult patients aged 19 years or older
- Patients currently using or scheduled to use 0.5% moxifloxacin eye drops for ophthalmic surgery or ocular surface diseases (dry eye, Sjogren's syndrome, Stevens-Johnson syndrome, graft versus host disease)
- Patients who agree to understand and comply with the clinical trial protocol's medical examinations and follow-up
You will not qualify if you...
- Pregnant or planning to become pregnant, and lactating women
- Patients with intellectual disabilities or psychiatric disorders deemed ineligible by the investigator
- Patients with hypersensitivity to 0.5% moxifloxacin eye drops or contraindications to their use
- Patients deemed impractical to participate based on medical, ethical, or compliance reasons by medical staff or observers
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Changho Yoon
Seoul, South Korea, 03080
Actively Recruiting
Research Team
C
Chang Ho Yoon, MD PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here